Daniel P. Lindholm

BioPharmaceuticals R&D
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

Journal: JAMA

Published: July 29, 2026

Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study.

Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study.

Journal: European heart journal

Published: July 08, 2026

Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023).

Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023).

Journal: Journal of the American College of Cardiology

Published: October 09, 2025

SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications.

SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications.

Journal: Diabetes, obesity & metabolism

Published: October 02, 2025

A deep learning ECG model for identification and localization of occlusion myocardial infarction.

A deep learning ECG model for identification and localization of occlusion myocardial infarction.

Journal: Nature communications

Published: July 24, 2025

A deep learning ECG model for identification and localization of occlusion myocardial infarction.

A deep learning ECG model for identification and localization of occlusion myocardial infarction.

Journal: Nature communications

Published: July 24, 2025

Reply to 'The patterns and changes of heart failure treatment in the last years of life still need further study'.

Reply to 'The patterns and changes of heart failure treatment in the last years of life still need further study'.

Journal: European journal of heart failure

Published: October 10, 2024

Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals.

Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals.

Journal: European journal of heart failure

Published: May 24, 2024

Regional assessment of availability for transcatheter aortic valve implantation in Sweden: a long-term observational study.

Regional assessment of availability for transcatheter aortic valve implantation in Sweden: a long-term observational study.

Journal: European heart journal. Quality of care & clinical outcomes

Published: October 25, 2023

Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.

Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.

Journal: European journal of heart failure

Published: May 22, 2023

Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.

Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.

Journal: Nature medicine

Published: March 18, 2023

Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.

Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.

Journal: American heart journal

Published: February 14, 2023

Showing 1-12 of 75

Last Updated: 09/26/2026